Can the beneficial effect of Hemocontrol on blood pressure during dialysis be explained by higher blood levels of vasopressin. A pilot study.
Completed
- Conditions
- invloed van hemodialyse op afgifte van het hormoon vasopressinedialysis hypotension10038430
- Registration Number
- NL-OMON35305
- Lead Sponsor
- Dialyse Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
•Hypotension-prone dialysis patients including patients who have stable hemodialysis session on Hemocontrol but previously had dialysis hypotension on standard hemodialysis
• Patients in whom frequently more than 3 liter fluid has to be ultrafiltered during hemodialysis.
Exclusion Criteria
• Patients on hemodialysis duration < 4 hours.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The course of plasma vasopressin levels, sodium, urea, glucose and plasma<br /><br>osmolarity.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Registration of blood volume, blood pressure and heart rate.<br /><br>All research-dialyses during the 1st dialysis of the week<br /><br>Registration of the attitude of the patient during hemodialysis and what the<br /><br>patient eats and drinks during hemodialysis.</p><br>